Pertussis seroprevalence in adults, post-partum women and umbilical cord blood;Estudio de seroprevalencia de coqueluche en adultos jóvenes, mujeres en puerperio inmediato y sangre del cordón umbilical

Archivos Argentinos de Pediatria

Volumn 112, Issue 4, 2014, Pages 315-322

  Fallo, Aurelia ^a   Manonelles, Gabriela ^a   Hozbor, Daniela ^b   Lara, Claudia ^c   Huespe, Miguel ^d   Mazzeo, Silvina ^d   Canle, Oscar ^a   Galas, Marcelo ^c   López, Eduardo ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c National Reference Pertussis Laboratory Clinical Bacteriology Dr Carlos G Malbrán   (Argentina)

^d Hospital Santojanni Buenos Aires   (Argentina)

Author keywords

Pertussis; Prevalence; Prevention and control

Indexed keywords

BACTERIUM ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BORDETELLA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PERTUSSIS; PLACENTAL TRANSFER; PUERPERIUM; SEROPREVALENCE; UMBILICAL CORD BLOOD; ADOLESCENT; BLOOD; BORDETELLA PERTUSSIS; EPIDEMIOLOGY; FETUS BLOOD; IMMUNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; FEMALE; FETAL BLOOD; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; WHOOPING COUGH; YOUNG ADULT;

EID: 84905822979     PISSN: 03250075     EISSN: 16683501     Source Type: Journal    
DOI: 10.5546/aap.2014.eng.315     Document Type: Article

References (35)

1. American Academy of Pediatrics. Pertussis. En: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2009 Report of the Committee on In!ectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009.Pages.504-19.
2. Tan T,Trindade E,Skowronsky D.Epidemiology of pertussis. Pediatr Infect Dis J 2005;24:S10-S18.
3. Global Immunization Data, World Health Organization (WHO)/UNICEF, November 2011.
4. Ministerio de Salud de la República Argentina, Boletín IntegradodeVigilanciaN.o 127,SE27,Vigilancia de Coqueluche, julio de 2012. Págs.15-19.
5. Bamberger E, Srugo I. What is new in pertussis? Eur J Pediatr 2008;167:133-9.
6. Bonmarin I, Lévy-Bruhl D, Baron S, Guiso N, et al. Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill 2007;12:34-8.
7. Lasserre A, Laurent E, Turbelin C, Hanslik T, et al. Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009. Euro Surveill 2011;16(5). [Available at: http://www.eurosurveillance.org/ViewArticle.aspx/ArticleId19783].
8. Tran Minh NN, He Q, Edelman K, et al. Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children. Pediatr Infect Dis J 1999;18(4):366-70.
9. Granstrom M, Olinder-Nielsen AM, Holmblad P, et al. Specific immunoglobulin for treatment of whooping cough. Lancet 1991;338,1230-3.
10. Organización Panamericana de la Salud/OMS. Presente y futuro de las inmunizaciones.Washington DC: Organización Panamericana de la Salud; 1990. [Serie Paltex para ejecutores de programas de salud (ISBN 92 75 710287); No 22: 62].
11. Moore DM, Mathias RG. Patterns of susceptibility in an outbreak of Bordetella pertussis: evidence from a communitybased study. Can J Infect Dis 2002;13:305-10.
12. Wang Ch, Zhu QR. Seroprevalence of Bordetella pertussis Antibody in Children and Adolescents in China. Pediatr Infect Dis J 2011;30:593-6.
13. Greenberg D. Pertussis in adolescents increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr InfectDis J 2005;24:721-8.
14. Manonelles G, Céccoli C, Fallo A, López E, et al. Impacto clínico-epidemiológico de la tos convulsa y análisis de costos en niños internados. Rev Hosp Niños B Aires 2009;51:3-9.
15. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985-9.
16. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007;26:293-9.
17. Healy CM, Munoz FM, Rench MA, Halasa NB, et al. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004;190:335-40.
18. Plans P, Jansa J, Doshi N, Harrison TG, et al. Prevalence of pertussis antibodies in umbilical cord blood samples in Catalonia, Spain. Pediatr Infect Dis J 2008;11:1023-5.
19. Schlaudecker E, McNeal M, Dodd C, Ranz J, Steinhoff M. Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis 2012;206:1670-3.
20. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerging Infectious Deseases 2006;12(11):1638-43.
21. Vanden Berg JP, Westerbeek EA, Berbers GA, van Gageldonk PG, et al. Transplacental Transport of IgG Antibodies Specific for Pertussis, Diphtheria, Tetanus, Haemophilus influenzae Type b, and Neisseria meningitides serogroup c is lower in preterm compared with term infants. Pediatr Infect Dis J 2010;29:801-5.
22. Gonik B, Puder KS, Gonik N, Kruger Ml. Seroprevalence of Bordetella pertussis antibodies in mothers and their new born infants. Infect Dis Obstet Gynecol 2005;13:59-61.
23. Healy CM, Rench MA, Edwards KM, Baker CJ. Pertussis serostatus among neonates born to Hispanic women.Clin Infect Dis 2006;42(10):1439-42.
24. Castagnini LA, Healy CM, Rench MA, Wootton SH, et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012;54:78-84.
25. Healy CM, Rench MA, Castagnini LA, Baker CJ. Pertussis immunization in a high-risk post partum population. Vaccine 2009;27:5599-602.
26. American Academy of Pediatrics, Committee on Infectious Diseases. Preventionof pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 2006;117(3):965-77.
27. World Health Organization Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010;85:385-400.
28. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged 12months-Advisory Committee on Immunization Practices (ACIP). 2011;60:1424-6.
29. Halperin BA, Morris A, Mackinnon-Cameron D, Mutch J, et al. Kinetics of the antibody response to tetanus-diphtheriaacellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis 2011;53(9):885-92.
30. Belloni C, De Silvestri A, Tinelli C, Avanzini MA, et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003;111:1042-5.
31. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010;29:209-15.
32. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, et al. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008;153:327-32.
33. Knuf M, Schmitt HJ, Jacquet JM, Collard A, et al. Booster vaccination after neonatal priming with acellular pertussis vaccine. J Pediatr 2010;156:675-8.
34. Leuridan E, Hens N, Peeters N, De Witte L, et al. Effect of a prepregnancy pertussis booster dose on maternal antibodytiters in young infants. Pediatr Infect Dis J 2011;30:608-10.
35. Ministerio de Salud de la Nación. PRONACEI. Manuales y lineamientos. Fundamentos de la vacunación de mujeres embarazadas con vacuna triple bacteriana acelular (Tdap). 2012.